[New] Alabama becomes the fortieth US state where medical cannabis is legally accessible, with three further dispensary companies expected to open additional sites by summer 2026.
Business of Cannabis
[New] BUSINESS TerrAscend Corp. announced preliminary expected quarterly net revenue of $65.5 million, Canadian retailers sold C$ 440.5 million worth of legal cannabis products in February.
Marijuana Moment
Schedule III brings cannabis into the fold of federal regulation, which means the FDA will likely take a more active role in product safety and labeling.
Goldleaf
American cannabis companies may soon be able to export products to international markets, while foreign pharmaceutical companies will invest in U.S. cannabis research and development.
Secret Nature
The Department of Justice announced it will place FDA-approved and state-regulated medical marijuana products into Schedule III, a move that recognizes their medical use while maintaining federal oversight.
OpenLoop Health, Inc.
The IRS plans to offer tax guidance for state-legal medical cannabis companies.
The Blunt Truth
The cannabis industry is expected to contribute more than $123 billion in economic impact in 2025, and that momentum is carrying forward into 2026, creating opportunities for stores that can adapt to consumer behaviour.
Marijuana Business Conference & Expo
The Missouri Division of Cannabis Regulation filed proposed rules to create a new class of marijuana research licenses and will be accepting public feedback throughout May.
Marijuana Moment
The federal government acknowledging marijuana's medical value is not only symbolically powerful but also could serve as a permissive signal to state-level lawmakers currently weighing cannabis legislation.
CNN
The future of cannabis policy in the United States may be uneven - that it may reflect not only the kind of expansion many have come to expect, but also a concurrent legislative and regulatory retrenchment.
Rockefeller Institute of Government
The political landscape for cannabis rescheduling has shifted with the incoming Trump administration signaling readiness to advance federal rescheduling efforts, which could substantially alter the regulatory and research environment for cannabis medicine.
CED Clinic
There continues to be a steady decline in youth cannabis use following the legalization of marijuana for adults - despite fears of opponents who claimed it would lead to skyrocketing teen consumption. / USAMarijuana Moment
For Canadian cannabis brands and retailers in other legal jurisdictions, the next few years will likely reward operators who can do three things well.
Juiced Digital Agency Inc.
